Four bioavailable peptides from chia protein hydrolysate (AGDAHWTY, VDAHPIKAM, PNYHPNPR, ALPPGAVHW) were identified as likely contributors to antioxidant and ACE inhibitory activity after simulated digestion and absorption.
4 bioavailable peptides identifiedAGDAHWTY, VDAHPIKAM, PNYHPNPR, ALPPGAVHW from chia protein with antioxidant and ACE inhibitor potential
What the researchers found
Four bioavailable peptides from chia protein hydrolysate were identified through absorption modeling and computational analysis as primary contributors to antioxidant and ACE inhibitory bioactivities.
Why it matters
Identifying which specific peptides survive digestion, get absorbed, and reach target tissues is critical for understanding how food-derived peptides actually work in the body — moving beyond 'chia is healthy' to understanding exactly why.
The numbers in context
Alcalase enzyme used for hydrolysis; bioavailable peptidome characterized; in silico evaluation of antioxidant and ACE inhibitory potential.
How the study worked
In vitro/in silico study. Chia protein hydrolyzed with Alcalase, intestinal absorption simulated using Caco-2 cell transwell model, peptides identified by mass spectrometry, and bioactivity predicted using computational tools.
Who was studied
In vitro and in silico analysis of chia protein hydrolysate
What this study cannot tell us
In vitro absorption model — may not fully replicate human intestinal absorption. In silico bioactivity predictions need experimental validation. Single enzyme (Alcalase) used — different digestion conditions may yield different peptides. Actual plasma concentrations and tissue delivery not measured.
How to read the evidence
Preliminary evidence — in vitro absorption study with in silico bioactivity predictions. Needs in vivo validation of peptide bioavailability and bioactivity.
When this study was published
Published in 2024. Part of the growing field of food-derived bioactive peptide characterization.
The bigger picture
Food-derived bioactive peptides are an emerging field bridging nutrition and pharmacology. This study demonstrates a systematic approach to identifying which peptides in functional foods are actually bioavailable and bioactive — a methodology applicable to many food protein sources.
Questions still open
- Do these four chia peptides reach pharmacologically relevant concentrations in human blood after oral intake?
- Can chia protein hydrolysate lower blood pressure in a clinical trial?
- How does the bioactive peptide profile change with different chia preparation methods?
Common questions
Can eating chia seeds actually lower blood pressure?
How do peptides from food get into your body?
Read the original research
Identification of the Bioavailable Peptidome of Chia Protein Hydrolysate and the In Silico Evaluation of Its Antioxidant and ACE Inhibitory Potential.
Journal of agricultural and food chemistry, 72(6), 3189-3199
Citation
Villanueva, Alvaro; Rivero-Pino, Fernando; Martin, Maria E; Gonzalez-de la Rosa, Teresa; Montserrat-de la Paz, Sergio; Millan-Linares, Maria C. (2024). Identification of the Bioavailable Peptidome of Chia Protein Hydrolysate and the In Silico Evaluation of Its Antioxidant and ACE Inhibitory Potential.. Journal of agricultural and food chemistry, 72(6), 3189-3199. https://doi.org/10.1021/acs.jafc.3c05331